author-photo

Jolanta Citko

20

Papers

61

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Real‐world effectiveness and safety of direct‐acting antivirals in patients with liver cirrhosis and history of hepatic decompensation: Epi‐Ter2 Study

2021 Liver International
Show All
- Source
- Cite
- Save
Citations (2)
Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA.

2020 Expert Review of Anti-infective Therapy
Show All
- Source
- Cite
- Save
Citations (7)
THU-140-Characteristics of patients and effectiveness of chronic hepatitis C treatment during the initial 4 years of access to interferon-free therapy

2019 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
THU-197-Comparative effectiveness of 8 versus 12 weeks of ombitasvir/paritaprevir/ritonavir and dasabuvir in treatment-naive patients infected with HCV genotype 1b with non-advanced hepatic fibrosis

2019 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
Real life results of direct acting antiviral therapy for HCV infection in HIV–HCV-coinfected patients: Epi-Ter2 study

2019 Aids Care-psychological and Socio-medical Aspects of Aids\/hiv
Show All
- Source
- Cite
- Save
Citations (6)
THU-185-Effectiveness and safety of DAA-based treatment of hepatitis C patients with severe and end stage chronic kidney diseases-EpiTer-2 database analysis

2019 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of 8- versus 12-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C patients eligible for 8 week regimen in a real-world setting

2019 Archives of Medical Science
Show All
- Source
- Cite
- Save
Citations (1)
The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study

2018 BMC Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (3)
Interferon Free Therapy with and Without Ribavirin for Genotype 1 HCV Cirrhotic Patients in the Real World Experience

2018 Hepatitis Monthly
Show All
- Source
- Cite
- Save
Citations (2)
Treatment of HCV infection in Poland at the beginning of the interferon-free era-the EpiTer-2 study

2018 Journal of Viral Hepatitis
Show All
- Source
- Cite
- Save
Citations (16)